INTRODUCTION
The methylation status of DNA influences many biological processes during mammalian development and is known to be highly aberrant in cancer (Gal-Yam et al., 2008; Ooi et al., 2009 ). DNA methylation is a powerful mechanism of genome defense against transposons and other parasitic DNA (Goll and Bestor, 2005) ; in addition, promoter methylation in mammals has long been considered suppressive for gene expression (Klose and Bird, 2006) . Recent whole-genome analyses have provided insights into the complexity of methylation patterns in plant and animal species (Farthing et al., 2008; Feng et al., 2010a; Lister et al., 2009; Meissner et al., 2008; Zemach et al., 2010) . DNA methylation occurs primarily at CpG dinucleotides in mammals: CpG methylation marks that are lost on newly replicated DNA strands are faithfully restored by the maintenance DNA methyltransferase Dnmt1. In embryonic stem cells (ESCs), however, a substantial fraction of cytosine methylation occurs in non-CpG contexts, where it has been attributed to the activity of the de novo methyltransferases Dnmt3a and Dnmt3b (Lister et al., 2009; Ramsahoye et al., 2000) .
Dynamic changes in DNA methylation occur during early embryogenesis (reviewed in Feng et al., 2010b) . Shortly after fertilization, the paternal genome loses the methylcytosine mark prior to DNA replication, whereas the maternal genome loses the mark passively in early cell cycles before blastulation. De novo methylation by Dnmt3 occurs around the time of blastocyst implantation, to a greater extent in the inner cell mass (ICM), which remains pluripotent and gives rise to all cell types of the embryo proper, than in the outer trophectoderm (TE) layer, which is restricted to an extraembryonic fate and gives rise to the placenta (Reik et al., 2001) . During the formation of primordial germ cells in the mouse, a second wave of genome-wide demethylation occurs during which imprinted marks are erased; they are subsequently reset in the developing gametes through de novo DNA methylation. The tight regulation of DNA methylation and demethylation is developmentally of crucial importance because Dnmt-deficient (and therefore hypomethylated) ESCs and embryos lose lineage restriction and show transdifferentiation to the extraembryonic trophoblast lineage (Jackson et al., 2004; Ng et al., 2008) .
We recently identified the TET proteins TET1, TET2, and TET3 as a new family of enzymes that alter the methylation status of DNA Tahiliani et al., 2009) . TET proteins are 2-oxoglutarate (2OG)-and Fe(II)-dependent dioxygenases that catalyze the hydroxylation of 5-methylcytosine to 5-hydroxymethylcytosine (5hmC) in DNA. TET proteins and 5hmC have been reported in many different tissues, and both 5hmC and Tet expression/activity are tightly regulated during ESC differentiation (Ito et al., 2010; Ko et al., 2010; Kriaucionis and Heintz, 2009; Szwagierczak et al., 2010; Tahiliani et al., 2009 ). TET1 and TET2 are both implicated in cancer: TET1 is an MLL partner in rare cases of acute myeloid (AML) and lymphoid (ALL) leukemias, and loss-of-function of TET2 is strongly associated with AML as well as a variety of myelodysplastic syndromes and myeloproliferative disorders (see references in Ko et al., 2010) . Together, these data suggest that dysregulation of DNA methylation via TET proteins and hmC may have a role in ESC pluripotency, oncogenic transformation (especially of hematopoietic stem cells toward the myeloid lineage), and neuronal function.
Here, we describe the function of Tet proteins (and, by inference, 5hmC) in mouse ESCs. ESC lines are culture explants from the inner cell mass (ICM) of the developing blastocyst. They can be maintained in the proliferative, undifferentiated state in culture by using the cytokine leukemia inhibitory factor (LIF) to activate STAT3 and the serum component bone morphogenetic protein (BMP) to induce inhibitor-of-differentiation proteins. When given the appropriate cellular signals, they can differentiate into cellular derivatives of the three primary germ layers: ectoderm, mesoderm, and endoderm. Withdrawal of LIF from serum-containing media allows BMP to switch from supporting self-renewal to inducing mesodermal and endodermal differentiation while blocking entry into neural lineages; when grown in the absence of both LIF signals and serum, ESCs are predisposed to convert to a neuronal fate (Ying et al., 2003a (Ying et al., , 2003b . These features of self-renewal and ability to differentiate, characteristic of a pluripotent state, require a high degree of epigenetic plasticity. Genes crucial for pluripotency are kept active by a selforganizing network of transcription factors and are rapidly silenced by histone modifications and DNA methylation during differentiation, whereas genes that are required later in cellular differentiation are held in a transiently repressed state by chromatin modifications that are easily reversed. Because Tet proteins modify DNA methylation status, it was conceivable that they might influence the expression and functions of either or both classes of genes.
RESULTS

Tet1 and Tet2 Regulate 5hmC Levels in Mouse ESCs and Are Associated with the Pluripotent State
In culture conditions containing LIF and serum, Tet1 transcripts are present at high copy numbers in mouse ESCs, comparable to those of the pluripotency factor Oct4; Tet2 transcripts are about 5-fold less abundant than Tet1 but still well expressed;
and Tet3 transcript levels are very low ( Figure 1A ). Individual depletion of Tet1 or Tet2 mRNAs with SMARTpool siRNA duplexes (Figure S1A available online) resulted in a moderate decrease in 5hmC, whereas combined depletion of both enzymes reduced 5hmC levels by 75%-80% (Figures 1B and 1C; Figures S1B and S1C) . Thus, Tet1 and Tet2 together are responsible for the bulk of 5hmC production in mouse ESCs cultured in the presence of LIF. In contrast to a previous report (Ito et al., 2010) , we did not observe major changes in ESC morphology upon siRNA-mediated depletion of either Tet1 alone or both Tet1 and Tet2 ( Figure S1D ).
When plated on gelatin in the presence of LIF, ESCs largely retained expression of Tet1, Tet2, and Oct4 over 4 to 5 days. Within 3 days of LIF withdrawal, Tet1 and Tet2 mRNA levels declined to 25%-30% of starting levels, with a time course that paralleled the decline of Oct4 mRNA ( Figure 1D ), and differentiated epithelial-like cells were observed in 4 to 5 days. When the ESCs were treated with retinoic acid (RA; a potent stimulus for cellular differentiation) at the same time that LIF was withdrawn, Tet1, and Oct4 expression declined more rapidly ( Figure 1D ), and epithelial-like morphology was apparent earlier, by day 3. Tet3 mRNA levels increased more than 10-fold under these conditions (Figure 1D) . Under both conditions, 5hmC levels declined significantly, to 40%-60% of control  Figure 1E ); the moderate change (compared to that seen in Figures 1B and  1C ) likely reflects both the incomplete loss of Tet1 and Tet2 under conditions of LIF withdrawal and the upregulation of Tet3 in response to RA ( Figure 1D ).
We examined Tet expression and activity during reprogramming of mouse embryonic fibroblasts (MEFs) into induced pluripotent stem cells (iPSCs) by transduction with the four reprogramming transcription factors Oct4, Sox2, Klf4, and c-Myc (Takahashi and Yamanaka, 2006) . The starting population of fibroblasts expressed almost no Tet1 mRNA and only a basal level of Tet2 mRNA, but fully reprogrammed iPSCs that had reactivated an endogenous Oct4-GFP reporter (Yeom et al., 1996) displayed levels of Tet1 and Tet2 mRNA comparable to those in ESCs; Tet3 transcripts also decreased, approaching the low level observed in ESCs ( Figure 1F ). In parallel, 5hmC levels increased, both globally and at MspI sites, from almost undetectable in fibroblasts to levels typical of ESCs in iPSCs ( Figure 1G ). Similar results were obtained during reprogramming of mouse adult tail-tip fibroblasts into iPSCs (data not shown). Collectively, these data point to a strong association of Tet1, Tet2, and 5hmC with the pluripotent state in both ESCs and iPSCs and a contrasting association of Tet3 with the differentiated state.
Oct4 Regulates Tet mRNA Levels
We measured Tet mRNA levels during ESC differentiation induced by RNAi-mediated depletion of the key pluripotency factors Oct4, Sox2, and Nanog. ESCs treated with SMARTpool siRNA duplexes targeting Oct4 differentiated rapidly within 3 days. Differentiation induced by Sox2 RNAi was slower, requiring $5 days, but alkaline phosphatase-positive colonies were still present in ESCs treated with Nanog RNAi for 5 days ( Figure S2A ). We confirmed that each SMARTpool depleted expression of its target pluripotency factor ( Figure S2B ), although as expected, depletion of each pluripotency factor in ESCs also downregulated expression of the others because of known cross-regulatory and cooperative interactions (Chew et al., 2005; Loh et al., 2006) . Oct4 and Sox2 RNAi resulted in potent repression of Tet1 and Tet2 mRNA, to < 20% and $30% of control levels, respectively; Tet3 mRNA was upregulated by $4-fold and $2-fold (Figure 2A) . Nanog RNAi had almost no effect on Tet1 and Tet3 while reducing Tet2 expression moderately, to $60% of control. TLC analysis at day 5 showed a marked loss of 5hmC at MspI sites only in cells treated with Oct4 siRNA ( Figure 2B ).
Chromatin immunoprecipitation of biotin-tagged Oct4 from ESCs stably expressing the BirA biotin ligase (Kim et al., 2008) showed that Oct4 bound to sites located within conserved noncoding sequence (CNS) regions of both the Tet1 and Tet2 genes ( Figures 2C-2H) . In both cases, the sites resembled consensus Oct4-Sox2 composite sites (Loh et al., 2006) and especially the Oct4 portion of the site was strongly conserved between human and mouse ( Figures 2E and 2H ). Oct4 binding sites were not detected in other CNS regions of the Tet1 locus ( Figures  S2C and S2D ) or at two other predicted Oct4-Sox2 binding elements in CNS regions at $À140 kb and À200 kb 5 0 of the Tet2 transcription start site. Although we have not tested formally whether these conserved Oct4-Sox2 composite sites function as transcriptional regulatory elements, the combined data suggest strongly that Tet1 and Tet2 are regulated by the Oct4-Sox2 complex.
Tet1 Depletion Skews ESC Differentiation
We characterized gene expression in ES cells after siRNAmediated depletion of each of the three Tet proteins by quantitative RT-PCR. Tet mRNAs were maximally depleted by 3 days of transfection. Tet1 depletion had no effect on Tet2 mRNA expression and vice versa ( Figure S1A ). In contrast to a previous report that Tet1 depletion led to diminished Nanog mRNA and protein (Ito et al., 2010) , Tet depletion did not affect expression of the key pluripotency factors Oct4, Sox2 and Nanog under our conditions for up to 5 days ( Figure 3A) , nor was there a marked change in the undifferentiated appearance of ESCs maintained in LIF ( Figure S1D ). Rather, Tet1 depletion resulted in reproducible changes in expression of a panel of lineage-specific markers within 3-5 days: there was a reproducible increase in expression of mRNAs encoding the trophectoderm markers Cdx2, Eomes, and Hand1, and a consistent decrease in expression of the neuroectoderm markers Pax6 and Neurod1 and the Nodal antagonists Lefty1 and Lefty2 (Figure 3A , Figure S3A , and data not shown). Tet2 depletion had no effect on trophectoderm, endoderm, and mesoderm markers but consistently caused a small increase in expression of Pax6, Neurod1, Lefty1, and Lefty2 ( Figure 3A and Figure S3A ), whereas Tet3 knockdown caused a 50% repression of Lefty2 but otherwise had no effect on all other targets tested (Figure S3A and data not shown). Combined depletion of Tet1 and Tet2, shown above to decrease genomic 5hmC levels almost to baseline ( Figures 1B and 1C) , had a similar but less striking effect compared to Tet1 depletion alone ( Figure 3A) , suggesting that Tet2 antagonizes the dominant effect of Tet1 at specific target genes.
To explore the effect of prolonged depletion of Tet1 on ESC developmental potential, we generated ESC clones stably expressing shRNAs against Tet1 and Tet2. Two Tet1-depleted clones, generated using Tet1 shRNA#2, showed >80% decrease in Tet1 mRNA levels (Tet1-kd/shRNA#2.1 and #2.2; Figure S3B , left); likewise, two Tet2-depleted clones, generated using Tet2 siRNA sequences #1 and #3, showed $55% and $75% decrease in Tet2 mRNA levels, respectively (Tet2-kd/shRNA#1 and #3; Figure S3B , right). Control clones expressed an irrelevant shRNA (scramble [Scr]-kd) or shRNA directed against GFP (GFP-kd). The clones could be propagated serially on feeder cells in the absence of further selection and were morphologically indistinguishable from parental and control clones ( Figure S3C ). Growth proliferation rates of the selected Tet-kd clones were similar to or slightly enhanced compared to control clones ( Figure S3D ). Whole-genome transcriptome analysis of stable Tet1-kd versus control ESC clones largely confirmed the results from transient RNAi transfections; gene ontology (GO) analysis of differentially expressed genes yielded many terms related to embryonic development and cell-cycle regulation (Table S1 ). Possibly because of incomplete knockdown, most gene-expression changes in Tet1-kd ESCs were fairly modest ($2-to 5-fold), and the cells retained a genome-wide molecular signature typical of normal ESCs.
We injected control shRNA and Tet-kd ES clones intramuscularly into immunodeficient mice and observed teratoma Figures 3B-3D ). Histologically, all three primary germ layer lineages could be found in Tet1-kd teratomas, but the relative contributions of each lineage appeared altered compared to controls ( Figures 3C-D) . Tet1-kd teratomas contained predominantly immature glandular tissue with surrounding stromal cells, indicative of definitive endoderm and mesoderm respectively; many of the glandular cells contained nuclei in mitotic phases, suggestive of a highly proliferative state ( Figure 3E ). There was considerably less neuroectoderm in the teratoma and many regions with necrotic tissue and blood ( Figure 3D ). A striking feature was the presence of many giant cells with large nuclei, found especially within and near the necrotic regions but also forming distinct clusters ( Figure 3F ); many of these cells contained glycogen-rich inclusion bodies, indicative of trophoblastic giant cells of the extra-embryonic lineage ( Figure 3G ). These histological features were independent of tumor size because sizedmatched control teratomas grown to full size were typically not hemorrhagic, contained more neural tissue, and rarely contained any trophoblastic giant cells. Moreover, smaller Tet1-kd teratomas obtained with injection of fewer cells (10 5 instead of 10 6 ) still formed hemorrhagic tumors containing many giant cells ( Figures S3E and S3F) .
Like Tet1-kd clones, Tet2-kd clones also formed large hemorrhagic teratomas that grew more aggressively than controls (Figure 3H ). Both Tet2-kd clones, generated by stable expression of independent shRNA hairpins, displayed a similar phenotype of hemorrhagy, although the phenotype was stronger in Tet2-kd/ shRNA#3-derived teratomas, correlating with stronger constitutive Tet2 knockdown ( Figure S3A, right) . Despite the hemorrhagic appearance, there was more neuroectoderm contribution in Tet2-kd teratomas, such that apart from the appearance of regions with necrotic tissue, most cellular features still resembled those of control teratomas ( Figure 3I ). Trophoblastic giant cells were also less apparent in Tet2-kd compared to Tet1-kd teratomas, appearing in clusters in only one oversized tumor harvested but otherwise barely represented in all other Tet2-kd tumors (data not shown). We conclude that Tet1 loss-of-function in ESCs results in developmental skewing toward endoderm/ mesoderm and trophoblast lineages, whereas Tet2 loss-offunction maintains a tendency toward neuroectoderm.
Altered Developmental Potential of Tet1-Depleted ESCs: Skewing to Trophectoderm
The upregulation of transcripts encoding the trophectodermal transcription factors Cdx2 and Eomes ( Figure 3A) , and the appearance of trophoblastic giant cells in Tet1-kd tumors ( Figures 3F-3IG ), suggested that Tet1 deficiency might attenuate the normal restriction of ESCs to embryonic tissues and permit their transdifferentiation into extra-embryonic trophoblast derivatives. Indeed, a previous report showed that when Tet1 siRNA was injected together with a marker gene into mouse embryos at the two-cell stage, the marked (presumably Tet1-depleted) cells were moderately excluded from the inner cell mass (ICM) and enriched in the trophectoderm (Ito et al., 2010) .
To explore this phenotype further, we cultured control and Tet1-kd clones on feeders in the presence of FGF4 and heparin, but without exogenous LIF, a culture condition previously described to favor the derivation of trophoblast stem (TS) cells from the trophectoderm of blastocysts (Tanaka et al., 1998) . In these alternative ''TS'' culture conditions, Tet1 depletion did not result in obvious morphological changes: both control (scramble shRNA) and Tet1-kd ESCs formed dense undifferentiated colonies that tended to be flatter with jagged edges, thus showing some resemblance to true TS cells, which are flat with a ridge-like periphery ( Figure S4A ). After 2 weeks in TS cell culture conditions, we observed a robust and reproducible induction of Elf5 transcripts in Tet1-kd clones (50-to 200-fold increase in Elf5 mRNA over the low background expression seen in control clones, approaching $10%-20% of the levels observed in TS cells; Figure 4A ). Elf5 lies downstream of the early trophoblast lineage determinants Cdx2 and Eomes and was recently described as a commitment marker for the trophoblastic fate . Moreover, whole-genome gene set enrichment analysis of Tet1-kd clones compared to control clones in TS conditions revealed significant enrichment (both FDR q value and FWER p value of 0.02) of a core set of genes defining trophectodermal cell differentiation, including Cdx2, Eomes, and Tead4 ( Figure S4B ). Expression of intermediate trophoblast (Tpbpa) or differentiated giant cell markers (PL1) in Tet1-kd clones was not observed during the course of TS cell culture, suggesting that the cells were being sustained in a TS-like state without overt differentiation into trophoblasts. To further investigate trophectoderm skewing, we cultured the Tet1-kd/shRNA#2.1 ESC clone for 2 weeks in TS culture conditions, picked three subclones, Tet1-kd/shRNA#2.1-sc1, .2, Bonferroni's multiple comparison test are denoted: *p < 0.05; **p < 0.01; ***p < 0.001. For ESC morphology and knockdown efficiency of Oct4, Sox2, and Nanog, see Figure S2 . and .3 based on flattened TS-like morphology, and propagated them in TS culture conditions. Quantitative RT-PCR analysis of these subclones showed a dramatic induction of Cdx2, Eomes, and Elf5 expression compared to control shRNA and parental cell lines ( Figure 4B) ; again, however, expression of these TE markers in the subclones was only a fraction of levels in TS cells, suggesting that the cells are propagating as an intermediate cell type between the ESC and TS cell states.
The association of Tet1 knockdown with Cdx2, Eomes, and Elf5 activation suggested that Tet1 might function to repress trophectoderm development during early embryogenesis. To test this hypothesis, we injected GFP-labeled Tet1-kd ESC lines, cultured either in ESC or TS cell conditions, into mouse blastocysts and observed chimerism in mid-gestation (E10.5) embryos by GFP fluorescence. Typically, ESCs injected into the ICM of blastocysts contribute only to the developing embryo and not 
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Tet Enzymes Regulate ESC Differentiation to placental tissues (Beddington and Robertson, 1989) , and this was indeed observed with ESCs expressing a scrambled control shRNA ( Figure 4C ). Tet1-kd ESCs from ESC cultures also chimerized the developing embryo, consistent with our data from teratomas that differentiation into the three primary germ layers is not completely blocked; however, the contribution to embryos appeared reduced and in rare cases, GFP + cells could even be detected in placental tissue (manifested as spots of extraembryonic GFP + cells in one embryo, or as faint GFP + cells in another 2/35 embryos obtained from five uterine transfers) ( Figure 4D ). When the same GFP-labeled ESCs were cultured for 4 weeks in TS cell conditions, there was a marked reduction in the ability of both control and Tet1-kd clones to chimerize the embryos based on GFP fluorescence; this, in part, reflects a technical shortcoming because of silencing of GFP observed in prolonged TS culture conditions. However, injection of a Tet1-kd clone or subclone from TS cell culture occasionally produced embryos with bright aggregates of GFP-positive cells in the placenta ( Figure 4C ). The presence of GFP + cells in the placenta was confirmed by immunohistochemical staining for GFP ( Figure 4E ). In contrast, none of the control ESCs expressing control shRNA gave rise to any bright GFP-fluorescent cells in the placenta, whether cultured under ESCs or TS conditions. Together, these data suggest that a small subset of Tet1-kd ESCs cultured in either ESCs or TS conditions are able to cross an embryonic restriction barrier to colonize the placenta.
Altered Developmental Potential of Tet1-Depleted ESCs: Skewing to Mesendoderm
We asked whether the observed increase in the representation of cells of the mesoderm and endoderm lineages in teratomas formed from Tet1-kd ESCs ( Figure 3D ) could reflect decreased expression of the Nodal antagonist Lefty ( Figure 3A ). Nodal and Lefty are both members of the TGFb superfamily (Schier, 2009; Shen, 2007; Tabibzadeh and Hemmati-Brivanlou, 2006) . Nodal signals act as morphogens and are essential for the induction of mesoderm and definitive endoderm in the gastrulationstage embryo when uncommitted epiblast cells move through the primitive streak, a structure marked by expression of the transcription factor Brachyury (Bry) (Tam and Loebel, 2007) . Mesoderm is induced from the posterior primitive streak in response to Wnt or low levels of TGFb/Nodal/Activin signaling, whereas definitive endoderm arises in response to high, sustained Nodal/Activin signals from ''mesendoderm'' progenitors in the anterior posterior streak that are marked by expression of Foxa2 and Goosecoid. We postulated that Tet1 depletion, by decreasing Lefty expression, would increase Nodal signals and result in the mesoderm/endoderm skewing observed in our teratoma assays.
To test this hypothesis, we used the CD4-Foxa2/GFP-Bry ESC line (E14.1, 129/Ola) in which Brachyury and Foxa2 expression are read out as expression of GFP and a cell-surface receptor, human CD4, respectively (Gadue et al., 2006) . If Tet1 depletion in this cell line indeed led to mesoderm and/or endoderm skewing, this would be apparent in ESC in vitro differentiation assays as increased expression of Brachyury and/or Foxa2, respectively. We depleted Tet1 in CD4-Foxa2/GFP-Bry ESCs using two independent Tet1 siRNAs and then allowed the cells to differentiate into embryoid bodies (EB) for 4 days. During the last 2 days of differentiation, we supplemented some cultures with graded concentrations of TGFb family member Activin A (1, 5, or 25 ng/ml) as a positive control to stimulate mesoderm and endoderm formation. Unlike Nodal, Activin is not inhibited by Lefty (Chen and Shen, 2004) . As expected, Tet1 transcripts declined to $50% of control levels by day 2 of EB formation (Figure 1D ), but siRNA treatment decreased Tet1 mRNA expression even further (data not shown). Control siRNA-transfected ESCs remained CD4-and GFP-negative during EB differentiation, but treatment with Tet1 siRNA (especially siRNA#2) led to the emergence of subpopulations expressing CD4 and GFP indicating strong expression of Foxa2 and low expression of Brachyury, respectively ( Figure 5A , top panels; Figure 5B ). GFP-Bry and CD4-Foxa2 expression were increased in Tet1 siRNAtreated cells that were also exposed to low concentrations of activin (5 ng/ml) ( Figure 5A , middle panels; Figure 5B) . Similarly, when stable Tet1-kd ESC clones (v6.5 cell line) were subjected to in vitro EB differentiation, we again observed induction of Foxa2 and Brachyury as measured by qRT-PCR ( Figure 5C ).
We examined Nodal/Activin signaling in whole-cell lysates of control and Tet1-depleted EB at day 4 by western blotting (Figure 5D) . In control-siRNA-treated cells, high doses of Activin A (25 ng/ml) stimulated Smad2 phosphorylation, upregulation of Eomes, and upregulation of Lefty ( Figure 5D , lane 4; the Lefty antiserum recognizes both Lefty 1 and Lefty 2; note the particularly strong upregulation of high molecular weight forms of Eomes.) These results are consistent with previous reports that Eomes is a downstream target of Nodal/Activin signaling (Arnold et al., 2008; Brennan et al., 2001) and that both Nodal itself and the inhibitor Lefty are induced by Nodal/Activin signals in positive and negative autoregulatory feedback loops (Besser, 2004; Saijoh et al., 2000) . Notably, Tet1-depleted ESCs also showed increased Smad2 phosphorylation and increased Eomes expression in the absence of activin (particularly striking in the case of Tet1 siRNA#2, lane 9), suggesting that decreased levels of Tet1 promote increased signaling in the TGFb pathway. These effects of Tet1 depletion were potentiated by activin treatment (lanes 7, 10, and 11). Interestingly, Tet1 depletion abolished the activin-induced increase in Lefty expression.
Tet1 Depletion Has Complex Effects on DNA Methylation at Target Gene Promoters
Tet enzymes regulate DNA methylation by modifying 5mC and have been proposed to promote DNA demethylation in multiple ways . By converting 5mC to 5hmC, Tet proteins diminish DNA methylation. Moreover, because 5hmC is not recognized by Dnmt1, its presence would promote passive demethylation. Finally, 5hmC might be actively removed by a DNA repair system and replaced by unmodified cytosine. Consistent with these possibilities, the Nanog promoter has been reported to become hypermethylated in ESCs depleted of Tet1 (Ito et al., 2010) . In contrast, however, we have shown that Tet2 loss-of-function in myeloid tumors results in global hypomethylation rather than localized hypermethylation at CpG dinucleotides in the genome (Ko et al., 2010) .
To investigate the relation of Tet1 depletion to changes in DNA methylation, we examined the promoters of two Tet1-regulated genes, Lefty1 and Elf5. The Lefty1 promoter is hypomethylated in stem cells and hypermethylated in differentiated cells (Farthing et al., 2008) , whereas the Elf5 promoter is hypermethylated (and repressed) in ESCs compared to TS cells . We first examined DNA ''methylation'' at the Lefty1 promoter in ESCs depleted of Tet1 by RNAi, using the bisulfite sequencing technique, which does not distinguish 5mC and 5hmC . Compared to control-treated cells in which the locus was hypomethylated, Tet1-depleted ESCs showed an increase in CpG ''methylation'' levels at specific regions of the
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Tet Enzymes Regulate ESC Differentiation 1.4 kb Lefty1 promoter region ( Figure 6A) , consistent with the notion that Tet1 directly or indirectly regulates Lefty1 expression by facilitating DNA demethylation. In contrast, the Elf5 promoter was as highly ''methylated'' in Tet1-kd ESC subclones as in the parental ESCs (Figure 6B ), despite the fact that Elf5 transcripts were more highly expressed (Figures 4A and 4B ).
DISCUSSION
In this study, we report the functional roles of Tet proteins, a newly-discovered family of DNA-modifying enzymes, in mouse ESCs and iPSCs. We show that Tet1 and Tet2 are the key enzymes responsible for the presence of 5hmC in mouse ESCs and iPSCs, that their expression is regulated by Oct4, and that their activity (as judged by 5hmC levels) correlates closely with the pluripotent state. In contrast to a previous report (Ito et al., 2010) , acute RNAi-mediated depletion of Tet1 alone, or both Tet1 and Tet2, did not in our hands cause overt ESC differentiation, diminish ESC proliferation, or affect expression of the key pluripotency factors Oct4, Sox2, and Nanog. Rather, Tet1 depletion correlated with decreased expression of the Nodal antagonists Lefty1 and Lefty 2, increased expression of the mesoderm/ endoderm transcription factors Brachyury and Foxa2, and increased expression of the trophoectoderm transcription factors Cdx2, Eomes, and Elf5. While we have not yet established whether these genes are direct or indirect targets of Tet1, it is notable that each lies at a ''crossroads'' of cell-fate determination during embryonic development Tabibzadeh and Hemmati-Brivanlou, 2006) .
Tet enzymes are downstream targets of the transcription factor network that maintains ESC pluripotency. Oct4 depletion led to rapid ESC differentiation, a parallel strong decrease in Tet1 and Tet2 mRNA expression, and an increase in Tet3 mRNA expression. Sox2 RNAi had a similar but less dramatic effect. BIO-ChIP assays showed Oct4 binding to both the Tet1 and Tet2 loci at composite Oct4/Sox2 sites, suggesting strongly that Tet1 and Tet2 are directly regulated by the cooperative Oct4/Sox2 complex. A previous genome-wide ChIP-seq analysis showed Oct4 binding to the Tet2 locus (Chen et al., 2008) ; however, neither this nor earlier studies (Boyer et al., 2005; Kim et al., 2008; Loh et al., 2006) identified Tet1 or Tet3 as Oct4 target genes, possibly because the signals did not reach statistical significance. We note that the mild effect of Nanog depletion on Tet2 gene expression may be indirect, through the ability of Nanog to regulate Oct4 and Sox2 (Loh et al., 2006) .
Our studies highlight a strong correlation between Tet1 and Tet2 expression and the pluripotent state. Stimuli that induced ESC differentiation-LIF withdrawal, RA addition, and Oct4 RNAi-caused loss of Tet1 and Tet2 expression and a parallel loss of genomic 5hmC. A previous kinetic analysis of gene expression in ESCs undergoing RA-induced differentiation also identified Tet1 (D10Ertd17e) as one of 65 rapidly downregulated candidate genes (Ivanova et al., 2006) ; however, Tet1 was not characterized further in this study, because-as also observed in our hands-shRNA-mediated knockdown of Tet1 did not dramatically affect morphology or alkaline phosphatase activity in ESCs. Conversely, reprogramming of fibroblasts to iPSCs was associated with increases in Tet1, Tet2, and 5hmC, and combined depletion of both Tet1 and Tet2 during early reprogramming by doxycycline-inducible RNAi reduced the number of iPSC colonies by about 50% (K.P.K., C.A.S., G.M., and A.R., unpublished data). A formal demonstration of the role of Tet enzymes in iPSC reprogramming will require the use of robust overexpression systems as well as fibroblasts from Tetdeficient mice. At several genes examined (e.g., Cdx2, Eomes, Lefty, Pax6), the effects of Tet1 depletion were dominant over an often mildly opposing effect of Tet2 depletion. Since both enzymes catalyze the conversion of 5mC to 5hmC, it is likely that they are recruited to disparate (possibly overlapping) sets of target genes and in turn recruit distinct transcriptional regulatory complexes through their divergent N-terminal regions. Notably, TET2 and 5hmC are also expressed, albeit at lower levels, in other tissues and cell types including hematopoietic stem cells (HSCs) (Delhommeau et al., 2009; Ito et al., 2010; Ko et al., 2010) ; thus, TET2 may regulate cell-fate decisions in adult stem/precursor cells as well. Indeed, RNAi-mediated depletion of Tet2 in early hematopoietic precursors resulted in skewed differentiation, with an enhanced propensity to commit to the myeloid lineage in response to appropriate cytokines in vitro (Ko et al., 2010) .
The gene expression changes observed in ESCs in response to acute Tet1 depletion were consistent with the developmental effects observed in teratoma assays in vivo and embryoid body formation in vitro. Teratomas formed by Tet1 and Tet2-kd ESCs contained cells from all three germ layers, albeit with altered relative contributions compared to control ESCs, indicating that Tet1 and Tet2-kd ESCs retained pluripotency. Tet1-kd teratomas contained a high proportion of cells of the definitive endoderm and mesoderm lineages; cells of the neuroectoderm lineage were considerably fewer. Tet2-kd clones also formed large hemorrhagic teratomas but with greater contribution from neuroectoderm. These features are consistent with the role of Lefty proteins (positively regulated by Tet1, mildly repressed by Tet2) as inhibitors of the TGF-b family member Nodal. Downstream of Activin/Nodal receptors, moderate and strong inductive signals mediated by Smad2/3 support differentiation into mesoderm and definitive endoderm lineages marked by Brachyury and Foxa2 expression, respectively (Gadue et al., 2006; Kubo et al., 2004) . Thus, diminished Lefty expression associated with Tet1 depletion would be expected to increase Smad signaling under conditions where the Nodal pathway was active; increase expression of the downstream target of Nodal signaling, Eomes; increase Brachyury and Foxa2 expression in differentiation assays in vitro; and skew development toward mesoderm/endoderm lineages in vivo, exactly as actually observed. Reciprocally, the slight increase in Lefty expression caused by Tet2 depletion would be expected to decrease Smad signaling and decrease the constraint on neuroectoderm gene expression. Although downregulation of Pax6 upon Tet1 depletion can also skew differentiation of mesendoderm by causing loss of neural progenitors, we did not observe any perceptible loss of Pax6 and NeuroD1 proteins when Tet1-depleted ESCs were differentiated for 4 days into embryoid bodies (data not shown). Thus, small changes in gene expression in Tet1-kd ESCs can be amplified into major changes in the strength of Nodal/Activin signaling, resulting in pronounced mesendoderm skewing during ESC differentiation.
Tet1-kd teratomas also showed a marked increase in the number of trophoblastic giant cells, especially amidst hemorrhagic and necrotic tissue. Furthermore, Tet1-kd ESCs chimerized placental tissue ectopically in midgestation stage embryos following blastocyst injection, albeit at low frequency. Again, this tendency was also apparent in vitro: Tet1-kd ESCs showed only a small increase in expression of the trophectoderm markers Cdx2 and Eomes and did not express Elf5, but increased the expression of all three genes upon switching to TS culture conditions that promote derivation of trophoblast stem cells. Thus, an induction signal for differentiation (LIF withdrawal and supplementation with Fgf4 and heparin) accentuates the effect of Tet1 deficiency on lineage commitment markers.
Our data suggest a complex relation between Tet proteins and DNA methylation. Tet1 depletion resulted in increased DNA methylation at the Lefty1 promoter in parallel with decreased expression of Lefty1 mRNA and protein. These data are consistent with the possibility that Tet1 promotes hydroxymethylation of the Lefty1 promoter, facilitating demethylation and, hence, promoting Lefty1 transcription. This hypothesis is clearly inadequate in the case of Elf5, however. The Elf5 promoter is normally silenced in ESCs by DNA methylation, and its demethylation and activation are required for ESCs to differentiate into trophoblast derivatives . In contrast, we find that Tet1 depletion correlated with increased Elf5 expression and trophectoderm skewing even though ESCs, ESCs cultured under TS conditions, and Tet1-kd ESCs cultured under TS conditions show similar hypermethylation at the Elf5 promoter, compared to the hypomethylation observed in TS cells. Since conventional bisulfite sequencing does not distinguish 5mC and 5hmC Jin et al., 2010; Nestor et al., 2010) , we have not formally ruled out the possibility that 5hmC is present at a subset of CpG sites at the Elf5 promoter. Although further studies are required to ascertain whether Tet1 binds directly to Lefty, Elf5, or other target genes, it is clear that the effect of Tet1 on DNA methylation and gene expression in ESCs cannot be explained by the simple postulate that 5hmC is an intermediate in a DNA demethylation pathway. Because Elf5 is located downstream of the trophoblast differentiation cascade and is induced by the early trophoblast lineage determinants Cdx2 and Eomes, one possibility is that Tet1 depletion increases Elf5 expression indirectly, through upregulation of Cdx2 and Eomes.
In summary, our studies identify Tet proteins as key regulators of early embryonic differentiation. Our data suggest that these enzymes do not act alone but, rather, operate in coordination with developmental signals to regulate lineage determination at decision points that are critical for early lineage commitment. We propose that Tet1 functions downstream of Oct4 in the first lineage split between inner cell mass and trophectoderm to constrain Elf5 expression in the inner cell mass; later in development, when the epiblast differentiates into the three somatic germ layers, Tet1 coordinates the canalization of developmental pathways by regulating Lefty ( Figure S5 ). An understanding of the roles of Tet proteins and the epigenetic mark, 5hmC, in ESC function and embryonic development will require analysis of Tet-disrupted mice and the genome-wide localization of 5hmC.
EXPERIMENTAL PROCEDURES
Oct4 Binding Site Bioinformatics and Chromatin Immunoprecipitation Alignments between the mouse and human Tet1 gene loci were performed on the Vista Browser (http://pipeline.lbl.gov/cgi-bin/gateway2) to include all intervening untranscribed regions between neighboring genes. Putative Oct4-Sox2 consensus sites were detected by the EMBOSS program (http://emboss.sourceforge.net/docs/adminguide/node6.html) using the fuzznuc command line to detect the pattern ''C[AT]TTGTN(0,5)ATGCAAAT'' tolerating a mismatch of two bases. Predicted sites within CNS regions were manually assessed. PCR primers were designed to probe CNS regions at 1 kb intervals and are shown in Supplementary Information. ChIP reactions were performed as previously described . Samples were analyzed under similar conditions, and fold enrichments were calculated by comparing ChIP samples to genomic DNA controls after normalizing to GAPDH. 
Teratoma Formation
Chimera Generation
Fifteen ES or ES-TS cells labeled with GFP by lentiviral vectors were injected into mouse blastocysts and implanted by uterus transfer into pseudopregnant foster mothers using standard methods. Pregnant mice were sacrificed at day E10.5, and whole embryos were photographed with an inverted fluorescent microscope. Specimens were fixed overnight in 10% formalin, mounted in HistoGel (Richard-Allan Scientific, MI), and stored in 80% ethanol. Paraffin sections and anti-GFP staining were performed at the Specialized Rodent Histopathology Services, Brigham and Women's Hospital.
ESC Serum-free Embryoid Body Differentiation CD4-Foxa2/GFP-Bry ESCs were maintained in serum-containing media with feeder cells before adaptation on feeder-free gelatin-coated wells in serumfree culture media (Invitrogen, Carlsbad, CA unless otherwise indicated) consisting of Knockout DMEM/F12 supplemented with 0.53 of both N2 and B27, penicillin/streptomycin, 0.05% BSA, LIF (1% conditioned medium), human BMP4 (10 ng/ml; R&D Systems, Minneapolis, MN), and 1.5 3 10 À4 M 1-thioglycerol (Sigma, St. Louis, MO) as previously described (Gadue et al., 2006) . ESCs were adapted for two passages in serum/feeder-free culture and transfected at 1.5 3 10 5 cells/ml for 2 days with 50 nM siRNA using Lipofectamine RNAiMAX according to manufacturer's instructions. To induce embryoid body (EB) differentiation (day 0), cells were dissociated by TrypLE Express and cultured at 1 3 10 5 cells/ ml in serum-free differentiation media consisting of 75% Iscove's modified Dulbecco's medium and 25% Ham's F12 media supplemented with 0.53 of both N2 and B27 (without retinoic acid), 0.05% BSA, 50 mg/ml ascorbic acid (Sigma), and 4.5 3 10 À4 M 1-thioglycerol. At day 2, the EBs were dissociated with TrypLE Express and reaggregated in serum-free differentiation media with the addition of human activin A (R & D systems). Retransfections of siRNA were performed at days 0 and 2 of EB aggregation. At day 4, EBs generated were dissociated by incubation with trypsin and stained with anti-human CD4-phycoerythrin (BioLegend, San Diego, CA). The cells were analyzed by a FacsCalibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ) and data processed with FlowJo software (TreeS Star, Ashland, OR). Note that Tet1 siRNA#1 and #2 correspond to Tet1 siRNA 1.1 and 1.2, respectively, in Figure S1A . For unknown reasons, Tet1 siRNA#1 was less effective than siRNA#2 in CD4-Foxa2/GFP-Bry ESCs, although in v6.5 ESCs, the two siRNAs were equivalent (see Figure S1A ).
ACCESSION NUMBERS
Microarray data have been deposited in the GEO Database under the accession number GSE26900.
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